News Focus
News Focus
icon url

sukus

10/12/22 10:07 AM

#521268 RE: hoffmann6383 #521264

Nice.
icon url

CherryTree1

10/12/22 10:24 AM

#521272 RE: hoffmann6383 #521264

So this is DCVAX weasel-worded to sound like something different.
I would think NWBO patents would prevent them from doing this or require them to pay a hefty licensing fee if NWBO decided to license it.
icon url

Bright Boy

10/12/22 10:45 AM

#521282 RE: hoffmann6383 #521264

Having spoken to one of the mRNA experts about DCVax, I learned that mRNA is certainly fantastic, breakthrough technology, but it cannot compete with the DCVax personalized vaccine process, in that mRNA is able to identify most of the antigens commonly found in large tumor cancers ,but not all antigens that are specific to each individual patient. In dealing with treatments for deadly cancers like GBM, almost all is not good enough !!! Choosing a mRNA vaccine over DCVax is a bit of a "Russian Roulette" game of chance!!! I would think that as far as marketing DCVax, the choice between mRNA and DCVax would be an easy decision.

Cheers,

BB
icon url

dr_lowenstein

10/12/22 10:57 AM

#521294 RE: hoffmann6383 #521264

My what is Merck thinking they need some new “experts “ lol lol